December 2025 Newsletter
 December 2025 2025 was a year like no other in the pharma and biotech industry. As we near the end of another great year, we’re proud to reflect on the momentum and milestones at FUJIFILM Biotechnologies. We’re also excited to share a glimpse of what’s ahead in 2026, including new innovations and initiatives designed to advance development and manufacturing for our customers worldwide.
|
|---|
 |
|---|
Looking Back on 2025 |
|---|
 Hillerød, Denmark Facility Expansion The year started with a bang in January as we celebrated the opening of FUJIFILM Biotechnologies’ latest manufacturing expansion at the Hillerød site in Denmark. |  BIO 2025 In June, Fujifilm made a big splash at BIO debuting its new Fujifilm Life Sciences brand. Catch up on some of the highlights in the video. |  Holly Springs Facility Opening September saw the grand opening of our new manufacturing hub in Holly Springs. Learn more about our partners’ public announcements from Johnson & Johnson, Regeneron, and argenx. |
|---|
 CEO of the Year In late October, Lars Petersen was named CPHI CEO of the Year for his People First leadership mindset. Hear more on his achievements and challenges in a recent podcast, below. |  EcoVadis Award We’re thrilled to share that in November our Hillerød Site in Denmark was awarded the Gold EcoVadis sustainability rating – placing us in the top 5% of all companies assessed globally. |  Bioethics Committee Also in November, Fujifilm established a Bioethics Advisory Committee to strengthen ethical governance across its life sciences and healthcare operations. |
|---|
Hottest Topics from 2025 |
|---|
 | Future-Proofing a Volatile Supply Chain Through Modular Biomanufacturing Through continuous innovation, strategic investment, and long-term partnerships, kojoX is reshaping the industry, ensuring a more agile and futureproofed biomanufacturing ecosystem. |
|---|
 | “Predict First” Approach Discover strategies to enhance efficiency in monoclonal antibody bioprocess development. |
|---|
 | Gene Therapy Developments Learn how to unlock faster, more reliable viral gene therapy development with multiplex ddPCR. |
|---|
 | Critical Steps to Optimize Viral Vector Manufacturing with CDMOs Accelerate your viral vector programs with proven CDMO best practices that streamline development, safeguard quality, and control costs. |
|---|
What to Expect in 2026 |
|---|
 | UK Expansion to Open in Feb 2026 Our innovative bioproduction ecosystem continues to grow, with our next expansion in the UK due to open in February 2026. This new addition to our network will allow biopharma companies even more access to modular, scalable manufacturing capacity that meets demands from early clinical development to commercial launch. |
|---|
 | JP Morgan Healthcare Conference January 12-13, 2026 | Marriott Marquis Hotel, San Francisco |
|---|
 | Pharmapack- Workshop Session January 22, 2026 | Paris |
|---|
Visit our website:
https://fujifilmbiotechnologies.fujifilm.com/